SPIA
GPCR icon

Steward Partners Investment Advisory’s Structure Therapeutics GPCR Stock Holding History

Steward Partners Investment Advisory’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.1K Hold
1,400
– – ﹤0.01% 2739
2026
Q1 		$67.5K Sell
1,400
-1,140
-45% -$78K ﹤0.01% 2609
2025
Q4 		$177K Sell
2,540
-100
-4% -$4.08K ﹤0.01% 1982
2025
Q3 		$73.9K Hold
2,640
– – ﹤0.01% 2417
2025
Q2 		$54.8K Buy
2,640
+124
+5% +$2.73K ﹤0.01% 2431
2025
Q1 		$43.6K Buy
2,516
+402
+19% +$9.85K ﹤0.01% 2454
2024
Q4 		$57.3K Buy
2,114
+56
+3% +$1.99K ﹤0.01% 2268
2024
Q3 		$90.3K Buy
2,058
+1,000
+95% +$38.7K ﹤0.01% 1928
2024
Q2 		$41.5K Buy
+1,058
New +$43.4K ﹤0.01% 2192
2024
Q1 		– Sell
-679
Closed -$27.7K – 3608
2023
Q4 		$27.7K Buy
+679
New +$38.9K ﹤0.01% 2242

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Steward Partners Investment Advisory's GPCR Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 1,400 shares worth $75.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Steward Partners Investment Advisory first reported a position in GPCR in Q4 2023 and has held it in 10 quarters since. The position peaked at $177K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Steward Partners Investment Advisory held 1,400 shares of Structure Therapeutics worth $75.1K as of Q2 2026.
  • Steward Partners Investment Advisory left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2739 holding.
  • Steward Partners Investment Advisory first reported a position in Structure Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Steward Partners Investment Advisory's Structure Therapeutics position peaked at $177K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.